āĻšā§āĻŽBIIB âĸ NASDAQ
add
āĻŦāĻžāϝāĻŧā§āĻā§āύ
ā§§ā§Šā§Š.ā§§ā§Š$
āĻāĻŖā§āĻāĻž āĻĒāϰā§:(ā§Ļ.ā§Ļā§ā§Ļ%)-ā§Ļ.ā§Ļā§¯ā§Š
ā§§ā§Šā§Š.ā§Ļā§Ē$
āĻŦāύā§āϧ āĻāĻā§: ā§Ŧ āĻā§āύ, ā§Ž:ā§Ļā§Ļ:ā§Ļā§Ļ PM GMT -ā§Ē · USD · NASDAQ · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āϏā§āĻāĻāĻŽāĻžāϰā§āĻāĻŋāύ āϝā§āĻā§āϤāϰāĻžāώā§āĻā§āϰ-āĻ āϤāĻžāϞāĻŋāĻāĻžāĻā§āĻā§āϤ āϏāĻŋāĻāĻŋāĻāϰāĻŋāĻāĻŋāĻŽāĻžāϰā§āĻāĻŋāύ āϝā§āĻā§āϤāϰāĻžāώā§āĻā§āϰ-āĻ āĻšā§āĻĄāĻā§ā§āĻžāϰā§āĻāĻžāϰ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
ā§§ā§Šā§Ļ.ā§Šā§Ŧ$
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
ā§§ā§Šā§§.ā§Ēā§Ģ$ - ā§§ā§Šā§Š.ā§ā§¨$
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
ā§§ā§§ā§Ļ.ā§Ļā§Ē$ - ā§¨ā§Šā§.ā§¯ā§Ž$
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
⧧⧝.ā§Ģā§§āĻļāĻ¤Â āĻā§ USD
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
ā§§ā§Ŧ.ā§Žā§ŽÂ āϞāĻž
P/E āĻ
āύā§āĻĒāĻžāϤ
ā§§ā§Š.ā§§ā§Ģ
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
-
āĻĒā§āϰāĻžāĻāĻŽāĻžāϰāĻŋ āĻāĻā§āϏāĻā§āĻā§āĻ
NASDAQ
āĻŦāĻžāĻāĻžāϰ āϏāĻāĻŦāĻžāĻĻ
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
(USD) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ⧍ā§Ēā§Š.ā§§ā§Ļ āĻā§ | ā§Ŧ.ā§§ā§Š% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ā§§ā§§ā§.ā§§ā§¨Â āĻā§ | ā§Ļ.⧝ā§% |
āύā§āĻ āĻāύāĻāĻžāĻŽ | ⧍ā§Ē.ā§Ļā§Ģ āĻā§ | -ā§Šā§Ž.ā§Žā§% |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | ⧝.ā§Žā§¯ | -ā§Ē⧍.ā§Ēā§Š% |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | ā§Š.ā§Ļ⧍ | -ā§§ā§.ā§ā§§% |
EBITDA | ā§Žā§Ŧ.ā§Ģā§§Â āĻā§ | ā§§ā§Ļ.⧝⧍% |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | ⧍⧍.ā§ā§¨% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
(USD) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ⧍ā§Ģ⧝.ā§Žā§ŠÂ āĻā§ | ā§§ā§Ēā§§.ā§Žā§Ē% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | ā§¨ā§Ž.ā§Ļā§ŠāĻļāĻ¤Â āĻā§ | ā§Ģ.ā§Ģ⧍% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§§ā§§.ā§Ļā§ĢāĻļāĻ¤Â āĻā§ | -⧍.ā§Ŧā§Ē% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§§ā§Ŧ.ā§¯ā§ŽāĻļāĻ¤Â āĻā§ | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ā§§ā§Ē.ā§Ŧā§Ģ āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ā§§.⧧⧍ | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ā§Ŧ.ā§Ļā§Ž% | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | ā§.⧍ā§Ģ% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
(USD) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | ⧍ā§Ē.ā§Ļā§Ģ āĻā§ | -ā§Šā§Ž.ā§Žā§% |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | ⧍ā§Ģ.ā§¯ā§ŠÂ āĻā§ | -ā§Ģā§Š.ā§§ā§Š% |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§Ē.ā§ā§ŠÂ āĻā§ | ā§¨ā§Ž.ā§Šā§Š% |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -⧍.ā§Šā§Ļ āĻā§ | ⧝ā§Ē.ā§ā§% |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | ⧍⧍.ā§Šā§ŠÂ āĻā§ | ā§Žā§§ā§§.ā§Ēā§Š% |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| ā§Ģā§§.ā§Ēā§Ē āĻā§ | ā§Ēā§Ģ.ā§Ŧā§Ž% |
āϏāĻŽā§āĻĒāϰā§āĻā§
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Poland, Sweden, and Switzerland. Wikipedia
āϏāĻŋāĻāĻ
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
⧧⧝ā§ā§Ž
āϏāĻĻāϰ āĻĻāĻĒā§āϤāϰ
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
ā§,ā§Ŧā§Ļā§Ģ